DCTH

Emisphere: Crown Jewel In Oral B12	Analyzing Wednesday's Noteworthy Insider Buys And Sells	7 Healthcare Stocks With January Catalysts
Analyzing Friday's Noteworthy Insider Buys And Sells	Novel Cancer Treatment Gains Acceptance	Targeted Chemotherapy: The Perfect Balance Between Safety And Efficacy?
Hyper-Novel Investments For Targeting Cancer	Notable Micro Cap Insider Buys Last Week	Biotechnology And Drug Stocks Up For FDA Approval In August
Delcath Systems 's CEO Discusses Q2 2012 Results - Earnings Call Transcript	Cancer Treatment Need Is The Mother Of Novel Solutions	Delcath Systems: An Exclusive Interview With ROTH Capital Senior Analyst
Interview: Delcath's CEO Provides Details About The Resubmission Of The FDA's New Drug Application For CHEMOSAT	Delcath Systems: A Frustrating Stock With Quite A Bit Of Value Potential	Biotech Weekend Recap: Bears, Bears Everywhere
Delcath Systems Management Discusses Q3 2012 Results - Earnings Call Transcript	Delcath Systems' CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)	Q3 2012 Pharma Company Updates Indicate Upcoming Catalysts
Three Reasons Delcath Systems Appears Undervalued	Is Delcath The Post-Celsion Play On Liver Cancer?	Cancer Radiation Stocks To Consider: Delcath, Spectrum And IsoRay
The Business Of Cancer	Delcath Systems: 'Improving The Bicycle' In Chemotherapy	Delcath Systems: Bullish On Melblez FDA Panel Vote And Subsequent Approval

Main menu